PriceSensitive

Neurotech International launch digital-doctor for patients

ASX News, Health Care, Technology
ASX:NTI      MCAP $82.56M
05 June 2019 18:36 (AEST)

Image Sourced ShutterStock

Medical device company Neurotech International surged 150 per cent this morning after announcing a brand new virtual clinic model.

Mente Clinic, which is currently in a ‘pilot stage’, allows for medical clinicians to remotely monitor and interact with their patients. The digital clinic is accessible through online browsers, iOS and Android app stores.

Clients using video conferencing and instant messaging to organise appointments is just one of the many assets offered on the platform.

Company management outlined in its media release that the core function of Mente Clinic is to extend the reach of practitioners and to service patients living in remote areas.

Since the application is currently in a pilot-test, Neurotech has launched the ‘Early Adopters’ Program. Early Adopter users will receive discounts on the Mente Clinic subscription service.

Neurotech CEO Peter Griffiths expressed excitement for the Early Adopters Program and the feedback that will be gained throughout the app’s pilot test.

“We want our Early Adopters to play a leading role as we work to expand the reach of Mente. Through their participation in this program, they can benefit from introductory pricing and help us by providing ongoing feedback on Mente and its benefits,” he said.

Earlier this year in April, Neurotech reported quarterly net cash at $432,000. This current quarter, which is still unreported on, was estimated for a cash outflow of $375,000 in the same report.

Shares in NTI are currently trading at a price of 3.5 cents in a $1.9 million market cap.

Related News